C. jejuni is an antigenically and phenotypically diverse bacterium with important research value in biology and medicine. As a professional biology company, CD BioGlyco utilizes the "design-construct-test-learn" strategy of synthetic biology to conduct research and construction of C. jejuni engineering and provide our clients with a wide range of C. jejuni engineering services.
Designing biological components
We utilize specific analysis tools for the design of biological components in C. jejuni. We design and optimize promoters, terminators, and manipulators by predicting their structures.
Construct
The process of construction includes DNA synthesis, large fragment assembly, and gene editing.
We utilize a variety of methods such as microarray chips, oligonucleotide linkers mediated DNA assembly, and other methods to synthesize DNA in C. jejuni hosts and complete the seamless splicing of large fragments of DNA.
We utilize transcription activator-like effector (TAL effector), as well as C. jejuni's endogenous clustered regularly interspaced short palindromic repeats (CRISPR)-Cas-based system to rapidly realize gene insertion, deletion, and single-base editing operations.
Test
We utilize a variety of high-throughput or automated screening and detection technologies to detect and analyze optimal biological components and combinations. For example, expression testing of biological components, in vitro or in vivo testing of non-natural pathways, and analysis of spatiotemporal regulation and effects on growth and metabolism after cell factory modification.
Learn
We analyze different levels of "gene-RNA-protein-metabolism-phenotype" and construct a knowledge map of genotype-phenotype and metabolism regulatory networks by using a systems biology approach based on histology.
Fig.1 "Design-construct-test-learn" strategy. (CD BioGlyco)
We use a dual fluorescent reporter gene detection system, homologous recombination, and CRISPR-Cas system for gene knockout, insertion, site-directed mutagenesis, gene replacement, and seamless genome deletion in the C. jejuni system. After this series of operations, streamlined C. jejuni chassis cells can be efficiently prepared.
Fig.2 Chassis cell construction technologies. (CD BioGlyco)
In addition, we apply systems biology approaches such as genomics, transcriptomics, proteomics, metabolomics, and metabolic network modeling to analyze the linkage between genotypes and phenotypes of the mutant strains of C. jejuni, so that we provide abundant genomic data and genetic modification sites for the development of biocomponents and the rational design of C. jejuni, and continually improve the production efficiency of the target products.
Technology: In vivo experiment
Journal: Scientific Reports
IF: 4.6
Published: 2016
Results: In this research, the authors designed and synthesized a glycan-conjugated vaccine in which the N-glycan of C. jejuni was conjugated or fused to an Escherichia coli (E. coli) lipopolysaccharide core with the protein carrier GlycoTag. Then, using the protein-based or E. coli-demonstrated sugar-conjugate, the author vaccinated chickens in vivo. Their experimental results showed that C. jejuni colonization was reduced by up to 10 logs and was able to effectively induce N-glycan-specific IgY responses. Moreover, no selection against resistant C. jejuni variants was observed when the live E. coli vaccine was removed before the C. jejuni attack.
CD BioGlyco has top-notch biological technology and a team of experienced experts dedicated to advancing each client's project. Our professional research team provides custom experimental solutions according to our client's needs to ensure their satisfaction. Please feel free to
for more details.Reference